Canopy Growth (CGC) Receivables - Net (2017 - 2026)
Canopy Growth (CGC) posted Receivables - Net of $22.8 million for Q1 2026, down 2.36% sequentially from $23.3 million in Q4 2025, and down 38.07% YoY from $36.8 million in Q1 2025.
Canopy Growth (CGC) Receivables - Net (2017 - 2026) Analysis & Trends
Canopy Growth has reported Receivables - Net for 10 years, with the latest figure at $22.8 million in Q1 2026.
- Quarterly Receivables - Net fell 38.07% year-over-year to $22.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.8 million (down 38.07% YoY) and the FY2026 annual result came in at $26.5 million, down 28.06% from the prior year.
- Receivables - Net retreated to $22.8 million in Q1 2026 per CGC's latest filing, from $23.3 million in the prior quarter.
- Over five years, Receivables - Net peaked at $95.6 million in Q2 2023 and troughed at $17.8 million in Q3 2025.
- A 5-year average of $42.6 million and a median of $36.8 million in 2025 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2023 and 2024: Receivables - Net surged 47.27% in 2023, then plunged 66.73% in 2024.
- Over 5 years, Receivables - Net stood at $60.2 million in 2022, then decreased by 21.97% to $47.0 million in 2023, then decreased by 25.21% to $35.1 million in 2024, then slumped by 33.56% to $23.3 million in 2025, then declined by 2.36% to $22.8 million in 2026.
- According to Business Quant data, Receivables - Net over the past three periods registered $22.8 million, $23.3 million, and $17.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Canopy Growth | 441.18 Mn | 194.17 Mn | 16.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.79 Mn |
| Jun 30, 2026 | 30.79 Mn |
| Mar 31, 2026 | 22.78 Mn |
| Mar 31, 2026 | 22.78 Mn |
| Dec 31, 2025 | 23.33 Mn |
| Dec 31, 2025 | 23.33 Mn |
| Sep 30, 2025 | 17.84 Mn |
| Sep 30, 2025 | 17.84 Mn |
| Jun 30, 2025 | 36.11 Mn |
| Jun 30, 2025 | 36.11 Mn |
| Mar 31, 2025 | 36.78 Mn |
| Mar 31, 2025 | 36.78 Mn |
| Dec 31, 2024 | 35.12 Mn |
| Dec 31, 2024 | 35.12 Mn |
| Sep 30, 2024 | 26.77 Mn |
| Sep 30, 2024 | 26.77 Mn |
| Jun 30, 2024 | 31.81 Mn |
| Jun 30, 2024 | 31.81 Mn |
| Mar 31, 2024 | 38.48 Mn |
| Mar 31, 2024 | 38.48 Mn |